Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI

Launched by FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY · Dec 20, 2017

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • After half-dose ticagrelor (loading dose 90mg, and then 45mg bidpo.) treatment for 3 days, the platelet aggregation is effectively inhibited by light transmission aggregometry method and thromboela-stogram.
• • planned to undergo PCI recently
• • planned to DAPT for 1 year after PCI
• Exclusion Criteria:
• • taken adenosine diphosphate (ADP) receptor antagonists within 2 weeks
• • Platelet count \<100g/L;
• • A history of bleeding tendency;
• • Aspirin, ticagrelor or clopidogrel allergies;
• • Severe liver injury.

Trial Officials